Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Steroid Biochem Mol Biol ; 208: 105793, 2021 04.
Article in English | MEDLINE | ID: mdl-33271253

ABSTRACT

Steroidogenesis is strictly regulated at multiple levels, as produced steroid hormones are crucial to maintain physiological functions. Cytochrome P450 enzymes are key players in adrenal steroid hormone biosynthesis and function within short redox-chains in mitochondria and endoplasmic reticulum. However, mechanisms regulating supply of reducing equivalents in the mitochondrial CYP-dependent system are not fully understood. In the present work, we aimed to estimate how the specific steroids, substrates, intermediates and products of multistep reactions modulate protein-protein interactions between adrenodoxin (Adx) and mitochondrial CYP11 s. Using the SPR technology we determined that steroid substrates affect affinity and stability of CYP11s-Adx complexes in an isoform-specific mode. In particular, cholesterol induces a 4-fold increase in the rate of CYP11A1 - Adx complex formation without significant effect on dissociation (koff decreased ∼1.5-fold), overall increasing complex affinity. At the same time steroid substrates decrease the affinity of both CYP11B1 - Adx and CYP11B2 - Adx complexes, predominantly reducing their stability (4-7 fold). This finding reveals differentiation of protein-protein interactions within the mitochondrial pool of CYPs, which have the same electron donor. The regulation of electron supply by the substrates might affect the overall steroid hormones production. Our experimental data provide further insight into protein-protein interactions within CYP-dependent redox chains involved in steroidogenesis.


Subject(s)
Adrenodoxin/chemistry , Cytochrome P-450 CYP11B2/chemistry , Cytochrome P-450 Enzyme System/ultrastructure , Steroid 11-beta-Hydroxylase/chemistry , Adrenodoxin/genetics , Adrenodoxin/ultrastructure , Cytochrome P-450 CYP11B2/genetics , Cytochrome P-450 CYP11B2/ultrastructure , Cytochrome P-450 Enzyme System/chemistry , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Humans , Mitochondria/enzymology , Mitochondria/genetics , Mitochondria/ultrastructure , Oxidation-Reduction , Protein Binding , Protein Conformation , Protein Interaction Maps/genetics , Steroid 11-beta-Hydroxylase/genetics , Steroid 11-beta-Hydroxylase/ultrastructure , Steroids/biosynthesis , Steroids/chemistry , Steroids/metabolism , Substrate Specificity
2.
J Steroid Biochem Mol Biol ; 193: 105416, 2019 10.
Article in English | MEDLINE | ID: mdl-31247323

ABSTRACT

Oxysterols are derivatives of cholesterol and biologically active molecules that are involved in a number of functions, including cholesterol homeostasis, immune response, embryogenic development and pathophysiology of neurodegenerative diseases. Enzymes catalyzing their synthesis and metabolism are of particular interest as potential or evaluated drug targets. Here we report for the first time biochemical analysis of purified human oxysterol 7α-hydroxylase selective for 24-hydroxycholesterol. Binding analyses indicated a tight binding of the oxysterols and estrone. Ligand screening revealed that CYP39A1 binds with high affinity antifungal drugs and prostate cancer drug galeterone (TOK-001). Site-directed mutagenesis of conserved Asn residue in the active site revealed its crucial role for protein folding and heme incorporation. Developed protocol for expression and purification enables further investigation of this hepatic enzyme as off-target in development of specific drugs targeting cytochrome P450 enzymes.


Subject(s)
Azoles/metabolism , Estrone/metabolism , Steroid Hydroxylases/metabolism , Sterols/metabolism , Catalysis , Escherichia coli/genetics , Humans , Ligands , Recombinant Proteins/metabolism , Steroid Hydroxylases/genetics
3.
Biomed Khim ; 65(1): 63-66, 2019 Jan.
Article in Russian | MEDLINE | ID: mdl-30816099

ABSTRACT

Biosensor experiments on investigation of interaction between prostacyclin synthase (PGIS) and different proteins of the cytochrome P450 monooxygenase systems were perfomed. Interaction of PGIS with microsomal (CYP21A2, CYP2E1) and mitochondrial (CYP27A1, CYP11B1, CYP11B2, CYP11A1) cytochrome P450s was detected. Kinetic and equilibrium parameters of protein complexes formation were determined. Data obtained suggest an essential role of these hemoproteins interaction in regulation of prostacyclin and thromboxane A2 biosynthesis.


Subject(s)
Cytochrome P-450 Enzyme System/metabolism , Intramolecular Oxidoreductases/metabolism , Humans , Microsomes/enzymology , Mitochondria/enzymology , Prostaglandins I/biosynthesis , Thromboxane A2/biosynthesis
4.
Expert Opin Drug Discov ; 14(2): 143-151, 2019 02.
Article in English | MEDLINE | ID: mdl-30572739

ABSTRACT

INTRODUCTION: Cushing's syndrome (CS) is a metabolic disorder caused by chronic hypercortisolism. CS is associated with cardiovascular, metabolic, skeletal and psychological dysfunctions and can be fatal if left untreated. The first-line treatment for all forms of CS is a surgery. However, medical therapy has to be chosen if surgical resection is not an option or is deemed ineffective. Currently available therapeutics are either not selective and have side effects or are only available as an injection (pasireotide). Areas covered: The authors discuss the recent drug developments for the medical treatment of CS through two validated molecular targets. Specifically, the authors look at selective inhibitors of CYP11B1 that reduce cortisol production by inhibiting steroid 11beta-hydroxylase and glucocorticoid receptor (GR) antagonists that interrupt cortisol-mediating transcriptional regulation of related genes. Expert opinion: Patients with CS have limited treatment options; indeed, there is an unmet need for new compounds that target CYP11B1 selectively versus several steroidogenic enzymes and/or GR-signaling pathways. The complexity of steroid biosynthesis and signaling requires the application of structure-based drug discovery techniques that use molecular targets and highly similar off-targets. Significant differences in steroidogenesis between humans and other species necessitates caution over the choice of in vivo model for the preclinical evaluation of future potential compounds.


Subject(s)
Cushing Syndrome/drug therapy , Drug Design , Drug Discovery/methods , Animals , Cushing Syndrome/physiopathology , Drug Development/methods , Humans , Hydrocortisone/metabolism , Molecular Targeted Therapy , Receptors, Glucocorticoid/antagonists & inhibitors , Steroid 11-beta-Hydroxylase/antagonists & inhibitors
5.
Acta Naturae ; 9(4): 92-100, 2017.
Article in English | MEDLINE | ID: mdl-29340222

ABSTRACT

Thromboxane synthase (TBXAS1) catalyzes the isomerization reaction of prostaglandin H2 producing thromboxane A2, the autocrine and paracrine factor in many cell types. A high activity and metastability by these arachidonic acid derivatives suggests the existence of supramolecular structures that are involved in the regulation of the biosynthesis and directed translocation of thromboxane to the receptor. The objective of this study was to identify TBXAS1 protein partners from human liver tissue lysate using a complex approach based on the direct molecular fishing technique, LC-MS/MS protein identification, and protein-protein interaction validation by surface plasmon resonance (SPR). As a result, 12 potential TBXAS1 protein partners were identified, including the components regulating cytoskeleton organization (BBIP1 and ANKMY1), components of the coagulation cascade of human blood (SERPINA1, SERPINA3, APOH, FGA, and FN1), and the enzyme involved in the metabolism of xenobiotics and endogenous bioregulators (CYP2E1). SPR validation on the Biacore 3000 biosensor confirmed the effectiveness of the interaction between CYP2E1 (the enzyme that converts prostaglandin H2 to 12-HHT/thromboxane A2 proantagonist) and TBXAS1 (Kd = (4.3 ± 0.4) × 10-7 M). Importantly, the TBXAS1•CYP2E1 complex formation increases fivefold in the presence of isatin (indole-2,3-dione, a low-molecular nonpeptide endogenous bioregulator, a product of CYP2E1). These results suggest that the interaction between these hemoproteins is important in the regulation of the biosynthesis of eicosanoids.

6.
Biomed Khim ; 60(5): 528-37, 2014.
Article in Russian | MEDLINE | ID: mdl-25386880

ABSTRACT

The cholesterol biosynthesis regulation is the important part of the hypercholesterolemia diseases therapy. The inhibition of the post-squalene cholesterol biosynthesis steps provide the alternative to classic statin therapy. Sterol-14a-demethylase (CYP51) is one of the hypothetical targets for it. In this work the screening of the ability to interact with human CYP51 (CYP51A1) for the nature low-weight compounds with steroid-like scaffold were performed by integration of the surface plasmon resonance biosensor and spectral titration methods. The results of the selection were 4 compounds (betulafolientriol, holothurin A, teasaponin, capsicoside A) witch had high affinity to the CYP51A1 active site. These data extend the range of compounds which may be used as specific inhibitors of CYP51 and give the permission to suggest the dynamic of the enzyme.


Subject(s)
14-alpha Demethylase Inhibitors/pharmacology , Lanosterol/pharmacology , Sterol 14-Demethylase/metabolism , 14-alpha Demethylase Inhibitors/chemistry , Humans , Lanosterol/analogs & derivatives , Lanosterol/chemistry , Protein Binding , Surface Plasmon Resonance
7.
Biochemistry (Mosc) ; 75(5): 570-8, 2010 May.
Article in English | MEDLINE | ID: mdl-20632935

ABSTRACT

In the present work the role of conserved residue E429 of cytochrome P45011A1 has been studied. The charge neutralization of E429Q results in 3-fold decrease of K(d) as well as V(max) compared to the wild type hemoprotein indicating tighter binding and, as the result, the impaired dissociation of oxidized adrenodoxin from the complex. As cytochrome P45011A1-adrenodoxin complex formation is driven primarily by electrostatic interactions, the low activity of E429Q mutant is completely restored to that of wild type hemoprotein by increasing of ionic strength. The charge neutralization of the corresponding residue of rat cytochrome P45011B2 has the same effect: the activity is 10-fold decreased but it is restored by increasing of ionic strength without effect on the ratio of products formed. Thus, this is the first report on identification of residues involved in modulation of dissociation of redox partner from the complex with cytochrome P450s.


Subject(s)
Adrenodoxin/metabolism , Cholesterol Side-Chain Cleavage Enzyme/metabolism , Amino Acid Substitution , Animals , Cholesterol Side-Chain Cleavage Enzyme/chemistry , Cholesterol Side-Chain Cleavage Enzyme/genetics , Electron Transport , Glutamic Acid/chemistry , Kinetics , Mutagenesis, Site-Directed , Osmolar Concentration , Protein Binding , Rats , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Static Electricity
8.
Biochemistry (Mosc) ; 71(9): 1027-34, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17009958

ABSTRACT

To elucidate the role of Arg472 and C-terminal sequence of the mature form of cytochrome P450scc, a mitochondrial cytochrome P450, in the present work we have performed sequential removal of the C-terminal amino acid residues of the hemeprotein and evaluated their functional role in folding and catalysis. The removal of 2, 4, 7, or 9 amino acid residues (cytochrome P450scc mutants Delta2, Delta4, Delta7, and Delta9) does not significantly affect the physicochemical properties of the truncated forms of cytochrome P450scc, but results in significant increase in the expression level of the hemeprotein in Escherichia coli (Delta4 cytochrome P450scc mutant). However, removal of 10 C-terminal amino acid residues (Delta10 cytochrome P450scc) of mature form of cytochrome P450scc (replacement of codon for Arg472 for stop-codon) is followed by loss of the ability for correct folding in E. coli. Based on these data, it is concluded that the C-terminal amino acid residues of cytochrome P450scc (DeltaArg472-Ala481) play an important role in correct recombinant protein folding and heme binding by cytochrome P450scc during its expression in E. coli, while folding of mitochondrial cytochrome P450scc during its heterologous expression in bacterial cells is more similar to the folding of prokaryotic soluble cytochrome P450's than to microsomal cytochrome P450's.


Subject(s)
Cholesterol Side-Chain Cleavage Enzyme/chemistry , Amino Acid Sequence , Animals , Arginine/chemistry , Cattle , Cholesterol Side-Chain Cleavage Enzyme/metabolism , Circular Dichroism , Escherichia coli/enzymology , Mutagenesis, Site-Directed , Protein Folding , Protein Interaction Mapping , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism
9.
Biochemistry (Mosc) ; 70(6): 664-71, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16038609

ABSTRACT

Cytochrome P450scc and adrenodoxin are redox proteins of the electron transfer chain of the inner mitochondrial membrane steroid hydroxylases. In the present work site-directed mutagenesis of the charged residues of cytochrome P450scc and adrenodoxin, which might be involved in interaction, was used to study the nature of electrostatic contacts between the hemeprotein and the ferredoxin. The target residues for mutagenesis were selected based on the theoretical model of cytochrome P450scc-adrenodoxin complex and previously reported chemical modification studies of cytochrome P450scc. In the present work, to clarify the molecular mechanism of hemeprotein interaction with ferredoxin, we constructed cytochrome P450scc Lys267, Lys270, and Arg411 mutants and Glu47 mutant of adrenodoxin and analyzed their possible role in electrostatic interaction and the role of these residues in the functional activity of the proteins. Charge neutralization at positions Lys267 or Lys270 of cytochrome P450scc causes no significant effect on the physicochemical and functional properties of cytochrome P450scc. However, cytochrome P450scc mutant Arg411Gln was found to exhibit decreased binding affinity to adrenodoxin and lower activity in the cholesterol side chain cleavage reaction. Studies of the functional properties of Glu47Gln and Glu47Arg adrenodoxin mutants indicate that a negatively charged residue in the loop covering the Fe2S2 cluster, being important for maintenance of the correct architecture of these structural elements of ferredoxin, is not directly involved in electrostatic interaction with cytochrome P450scc. Moreover, our results indicate the presence of at least two different binding (contact) sites on the proximal surface of cytochrome P450scc with different electrostatic input to interaction with adrenodoxin. In the binary complex, the positively charged sites of the proximal surface of cytochrome P450scc well correspond to the two negatively charged sites of adrenodoxin: the "interaction" domain site and the "core" domain site.


Subject(s)
Adrenodoxin/chemistry , Cholesterol Side-Chain Cleavage Enzyme/chemistry , Protein Conformation , Adrenodoxin/genetics , Adrenodoxin/metabolism , Amino Acid Sequence , Amino Acid Substitution , Cholesterol Side-Chain Cleavage Enzyme/genetics , Cholesterol Side-Chain Cleavage Enzyme/metabolism , Cloning, Molecular , Electron Transport , Ferredoxin-NADP Reductase/metabolism , Ferredoxins/metabolism , Mutagenesis, Site-Directed , Protein Binding
10.
Biochemistry (Mosc) ; 66(5): 564-75, 2001 May.
Article in English | MEDLINE | ID: mdl-11405894

ABSTRACT

Cytochrome P450-dependent monooxygenases, in spite of their wide distribution, can be simply divided into a few groups differing in the location of the electron transfer chain and their composition. The two main groups of cytochrome P450-dependent monooxygenases are the mitochondrial and microsomal enzymes. While in two-component microsomal cytochrome P450-dependent monooxygenases electrons are supplied to cytochrome P450 by a flavoprotein (NADPH-cytochrome P450 reductase), in three-component mitochondrial monooxygenases the electrons are supplied to cytochrome P450 by a low molecular weight protein (ferredoxin). The interaction of cytochrome P450 with NADPH-cytochrome P450 reductase and ferredoxin is the subject of intensive studies. Using chemical modification, chemical cross-linking, and site-directed mutagenesis, we identified surface exposed positively charged residues of cytochrome P450scc which might be important for interaction with adrenodoxin. Theoretical analysis of the distribution of surface electrostatic potential in cytochrome P450 indicates that in contrast to microsomal monooxygenases, cytochromes P450 of mitochondrial type, and cholesterol side-chain cleavage cytochrome P450 (P450scc) in part, carry on the proximal surface an evidently positively charged site that is formed by residues Arg425 and Arg426. In the present work, to estimate the functional role of Arg425 and Arg426 of cytochrome P450scc, we used site-directed mutagenesis to replace these residues with glutamine. The results indicate that residues Arg425 and Arg426 are involved in the formation of a heme-binding center and electrostatic interaction of cytochrome P450scc with its physiological electron-transfer partner, adrenodoxin.


Subject(s)
Cholesterol Side-Chain Cleavage Enzyme/metabolism , Mutagenesis, Site-Directed , Protein Conformation , Adrenodoxin/chemistry , Adrenodoxin/genetics , Adrenodoxin/metabolism , Amino Acid Sequence , Animals , Binding Sites , Cattle , Cholesterol Side-Chain Cleavage Enzyme/chemistry , Cholesterol Side-Chain Cleavage Enzyme/genetics , Ferredoxins/chemistry , Ferredoxins/genetics , Ferredoxins/metabolism , Humans , Models, Molecular , Molecular Sequence Data , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Spectrophotometry, Ultraviolet
11.
Biochemistry (Mosc) ; 65(12): 1409-18, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11173513

ABSTRACT

Our previous chemical modification and cross-linking studies identified some positively charged amino acid residues of cytochrome P450scc that may be important for its interaction with adrenodoxin and for its functional activity. The present study was undertaken to further evaluate the role of these residues in the interaction of cytochrome P450scc with adrenodoxin using site-directed mutagenesis. Six cytochrome P450scc mutants containing replacements of the surface-exposed positively charged residues (Lys103Gln, Lys110Gln, Lys145Gln, Lys394Gln, Lys403Gln, and Lys405Gln) were expressed in E. coli cells, purified as a substrate-bound high-spin form, and characterized as compared to the wild-type protein. The replacement of the surface Lys residues does not dramatically change the protein folding or the heme pocket environment as judged from limited proteolysis and spectral studies of the cytochrome P450 mutants. The replacement of Lys in the N-terminal sequence of P450scc does not dramatically affect the activity of the heme protein. However, mutant Lys405Gln revealed rather dramatic loss of cholesterol side-chain cleavage activity, efficiency of enzymatic reduction in a reconstituted system, and apparent dissociation constant for adrenodoxin binding. The present results, together with previous findings, suggest that the changes in functional activity of mutant Lys405Gln may reflect the direct participation of this amino acid residue in the electrostatic interaction of cytochrome P450scc with its physiological partner, adrenodoxin.


Subject(s)
Cholesterol Side-Chain Cleavage Enzyme/genetics , Cholesterol Side-Chain Cleavage Enzyme/physiology , Lysine/chemistry , Mutagenesis, Site-Directed , Adrenodoxin/metabolism , Amino Acid Sequence , Animals , Cholesterol Side-Chain Cleavage Enzyme/chemistry , Circular Dichroism , Electrophoresis, Polyacrylamide Gel , Escherichia coli/metabolism , Glutamic Acid/chemistry , Heme/chemistry , Humans , Molecular Sequence Data , Protein Binding , Protein Folding , Sequence Homology, Amino Acid , Spectrophotometry , Thermodynamics , Time Factors
12.
Biochim Biophys Acta ; 1434(1): 31-43, 1999 Sep 14.
Article in English | MEDLINE | ID: mdl-10556557

ABSTRACT

Bovine adrenocortical cytochrome P450scc (P450scc) was expressed in Escherichia coli and purified as the substrate bound, high-spin complex (16.7 nmol of heme per mg of protein, expression level in E. coli about 400-700 nmol/l). The recombinant protein was characterized by comparison with native P450scc purified from adrenal cortex mitochondria. To study the interaction of the electron transfer proteins during the functioning of the heme protein, recombinant P450scc was selectively modified with fluorescein isothiocyanate (FITC). The present paper shows that modified P450scc, purified by affinity chromatography using adrenodoxin-Sepharose to remove non-covalently bound FITC, retains the functional activity of the unmodified enzyme, including its ability to bind adrenodoxin. Based on the efficiency of resonance fluorescence energy transfer in the donor-acceptor pair, FITC-heme, we calculated the distance between Lys(338), selectively labeled with the dye, and the heme of P450scc. The intensity of fluorescence from the label dramatically changes during: (a) denaturation of P450scc; (b) changing the spin state or redox potential of the heme protein; (c) formation of the carbon monoxide complex of reduced P450scc; (d) as well as during reactions of intermolecular interactions, such as changes of the state of aggregation, complex formation with the substrate, binding to the electron transfer partner adrenodoxin, or insertion of the protein into an artificial phospholipid membrane. Selective chemical modification of P450scc with FITC proved to be a very useful method to study the dynamics of conformational changes of the recombinant heme protein. The data obtained indicate that functionally important conformational changes of P450scc are large-scale ones, i.e. they are not limited only to changes in the dynamics of the protein active center. The results of the present study also indicate that chemical modification of Lys(338) of bovine adrenocortical P450scc does not dramatically alter the activity of the heme protein, but does result in a decrease of protein stability.


Subject(s)
Cholesterol Side-Chain Cleavage Enzyme/chemistry , Adrenal Cortex/chemistry , Animals , Cattle , Cholesterol Side-Chain Cleavage Enzyme/isolation & purification , Energy Transfer , Escherichia coli , Fluorescein-5-isothiocyanate/chemistry , Fluorescent Dyes/chemistry , Hemeproteins/chemistry , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification
13.
Biochemistry (Mosc) ; 64(9): 1079-88, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10521726

ABSTRACT

The conditions for heterologous expression of recombinant bovine adrenodoxin in E. coli have been optimized, thus reaching expression levels up to 12-14 micromoles per liter of culture medium. A highly efficient method for purification of this recombinant ferredoxin from the E. coli cells has been developed. The structural-functional properties of the highly purified recombinant protein have been characterized and compared to those of natural adrenodoxin purified from bovine adrenocortical mitochondria. In contrast to natural adrenodoxin, which is characterized by microheterogeneity, the recombinant adrenodoxin is homogeneous as judged by N- and C-terminal amino acid sequencing, and its sequence corresponds to the full-length mature form of adrenodoxin containing 128 amino acid residues. The interactions of the natural and recombinant adrenodoxins with cytochrome P450scc have been studied and compared with respect to: the efficiency of their enzymatic reduction of cytochrome P450scc in a reconstituted system; the ability of the immobilized adrenodoxins to bind cytochrome P450scc; the ability of the adrenodoxins to induce a spectral shift of cytochrome P450scc and to effect the average polarity of exposed tyrosines in the low-spin cytochrome P450scc. The recombinant adrenodoxin is functionally active and in the reduced state as well as at low ionic strength it displays higher affinity to cytochrome P450scc as compared to the natural bovine adrenocortical adrenodoxin. The possible role of the C-terminal sequence of the adrenodoxin molecule in its interaction with cytochrome P450scc as well as the advantages of using the recombinant protein instead of the natural one are discussed.


Subject(s)
Adrenodoxin/chemistry , Adrenodoxin/metabolism , Cholesterol Side-Chain Cleavage Enzyme/metabolism , Adrenodoxin/isolation & purification , Amino Acid Sequence , Animals , Cattle , Cholesterol Side-Chain Cleavage Enzyme/isolation & purification , Chromatography, Ion Exchange , Cloning, Molecular , Escherichia coli , Ferredoxin-NADP Reductase/isolation & purification , Ferredoxin-NADP Reductase/metabolism , Kinetics , Molecular Sequence Data , Peptide Fragments/chemistry , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...